Latest Articles about CYBX

St. Jude Expands Neuro Offerings - Analyst Blog

Zacks Equity Research — Mon, 10 Jun 2013 22:20:01 Z

Medical devices giant, St. Jude Medical ( STJ ) has entered into an exclusive distribution agreement with Spinal Modulation, Inc. to sell its Axium Neurostimulator System in the global

Quest and Hologic Extend Ties - Analyst Blog

Zacks Equity Research — Fri, 07 Jun 2013 22:27:57 Z

Leading player in the women's health market Hologic Inc . ( HOLX ) recently inked a non-exclusive agreement with Quest Diagnostics ( DGX ). As per the agreement, Quest Diagnostics will

Accuray Expands in France - Analyst Blog

Zacks Equity Research — Fri, 07 Jun 2013 17:29:09 Z

Radiosurgery systems maker, Accuray Incorporated ( ARAY ) announced that France-based Centre Oscar Lambret is the first to use its latest TomoHDA System to treat its patient. The advanced

MDT Cease IN.PACT Admiral Enrollment - Analyst Blog

Zacks Equity Research — Thu, 06 Jun 2013 22:27:46 Z

Medical devices major Medtronic ( MDT ) recently stated that it has enrolled a significant number of patients for the IN.PACT Admiral drug-eluting balloon studies. As a part of the

Company News for June 6, 2013 - Corporate Summary

Zacks Equity Research — Thu, 06 Jun 2013 18:30:53 Z

• Cyberonics, Inc. (NASDAQ: CYBX ) posted fourth quarter earnings per share of $0.46, ahead of the Zacks Consensus Estimate of $0.43 • Layne Christensen

CYBX Earnings Beat; Expects Strong FY14 - Analyst Blog

Zacks Equity Research — Thu, 06 Jun 2013 17:28:03 Z

Cyberonics ' ( CYBX ) fourth-quarter fiscal 2013 adjusted earnings per share (EPS) rose 21.1% to 46 cents, surpassing the Zacks Consensus Estimate of 43 cents. This represents the eighth

MDT's Catheter Gets Regulatory Approvals - Analyst Blog

Zacks Equity Research — Thu, 06 Jun 2013 02:27:51 Z

Leading medical devices player, Medtronic ( MDT ) has received clearance from both the US Food and Drug Administration (FDA) and the European CE Mark for its Pacific Plus percutaneous

Market Wrap for Wednesday, June 5: Stocks Plunge as Uncertainty Rises

Scott Rubin — Thu, 06 Jun 2013 00:25:35 Z

The U.S. stock market recorded its biggest loss in weeks on Tuesday after the Fed's Beige Book report showed that the economy is expanding only at a modest to moderate rate. A series of

ZMH Acquires NORMED - Analyst Blog

Zacks Equity Research — Wed, 05 Jun 2013 23:27:52 Z

Global orthopedic and surgical products company - Zimmer Holdings ( ZMH ) recently announced the acquisition of NORMED Medizin-Technik GmbH, a Germany-based medical company. However,

PerkinElmer Releases New Apps - Analyst Blog

Zacks Equity Research — Wed, 05 Jun 2013 22:27:32 Z

PerkinElmer Inc. ( PKI ), a company focused on health and the environment, recently revealed that the App Store now carries the Chem3D and ChemDraw apps with the company's Flick-to-Share

Mid-Day Market Update: Markets Extend Losses, Mattress Firm Surges On Earnings Beat

Jake L'Ecuyer — Wed, 05 Jun 2013 20:36:07 Z

Midway through trading Wednesday, the Dow traded down 0.76 percent to 15,062.00, while the NASDAQ fell 0.82 percent to 3,417.18. The S&P was also down, dropping 0.84 percent to

Mid-Morning Market Update: Markets Fall, Brown-Forman Posts Higher Profit

Jake L'Ecuyer — Wed, 05 Jun 2013 18:21:28 Z

Following the market opening Wednesday, the Dow traded down 0.23 percent to 15,142.59, while the NASDAQ fell 0.08 percent to 3,442.41. The S&P was also down, dropping 0.18 percent to

BSX Funding for Women's Health - Analyst Blog

Zacks Equity Research — Wed, 05 Jun 2013 00:27:09 Z

Keeping in line with its strategy of balanced expansion through all the segments, recently medical device major Boston Scientific Corp ( BSX ) came up with research and education funding of

Pre-Market Earnings Report for June 5, 2013 : BF/B, CYBX, HOV, THR, CVGW, LAYN, STRM

NASDAQ.com News — Wed, 05 Jun 2013 00:00:04 Z

The following companies are expected to report earnings prior to market open on 06/05/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Brown Forman Corporation

Another Client Win for Omnicell - Analyst Blog

Zacks Equity Research — Tue, 04 Jun 2013 23:29:00 Z

Omnicell Inc. ( OMCL ) continues to expand its customer base. Recently announced, this provider of end-to-end automation solutions for medication-use process will provide its G4 Unity